Published on 15 May 2024 on Zacks via Yahoo Finance
Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
Senseonics Holdings, Inc. SENS and Mercy, a leading healthcare system based in St. Louis, have inked a collaboration deal to revolutionize diabetes population health management. This partnership leverages Senseonics' Eversense Continuous Glucose Monitor (CGM) technology and Mercy's expertise in remote patient monitoring to enhance patient care and drive innovation in diabetes management.
The collaboration marks the first utilization of Senseonics' Eversense CGM technology across a healthcare system. Providers at Mercy plan to begin placing new Eversense devices with patients this July followed by other regions covered by Mercy throughout 2025.
Price Performance